0
ARTICLE |

Activation of Systemic Lupus Erythematosus by Drugs

STANLEY L. LEE, MD; ISAAC RIVERO, MD; MORRIS SIEGEL, MD
Arch Intern Med. 1966;117(5):620-626. doi:10.1001/archinte.1966.03870110012003.
Text Size: A A A
Published online

SYNDROMES with clinical, laboratory, and anatomical features identical with those of systemic lupus erythematosus have been reported after administration of certain drugs. A list of agents which have been implicated is contained in Table 1. The drugs listed do not seem to have a single common denominator either chemically or pharmacologically. With the exception of penicillin, they do have in common the feature that in each case, systemic lupus erythematosus has followed use of the drug in high dosages for periods in excess of two months.

The present study represents an attempt to determine what importance prior intensive drug therapy might have in the development of signs and symptoms of systemic lupus erythematosus.

Methods and Materials 

General Plan.  —Case records of patients diagnosed clinically as having systemic lupus erythematosus SLE were examined from the point of view of symptoms, diagnosis, and therapy administered before onset of systemic lupus erythematosus.Records

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs